Description

Acetamide, 2-[(1,4-Dihydro-5,6-Dimethyl-4-Oxothieno[2,3-D]Pyrimidin-2-Yl)Thio]-n-(5-Ethyl-1,3,4-Thiadiazol-2-Yl)- (9Ci) is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for the research and development of novel therapeutic agents, particularly in the fields of oncology and virology. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel thienopyrimidine-based drug candidates.
• Oncology Research: Used in the development of targeted cancer therapies, particularly kinase inhibitors.
• Antiviral Agent Development: Investigated as a precursor for compounds with potential antiviral activity.
• Biochemical Research: Employed as a reference standard or probe in biochemical and pharmacological studies.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development.
• Academic Research: Utilized in university and institutional labs for medicinal chemistry and heterocyclic compound research.

Basic Information

Product Name	Acetamide, 2-[(1,4-Dihydro-5,6-Dimethyl-4-Oxothieno[2,3-D]Pyrimidin-2-Yl)Thio]-n-(5-Ethyl-1,3,4-Thiadiazol-2-Yl)- (9Ci)
CAS No.	606108-38-7
Molecular Formula	C17H18N6O2S3
Molecular Weight	450.56 g/mol
Synonyms	2-[(1,4-Dihydro-5,6-dimethyl-4-oxothieno[2,3-d]pyrimidin-2-yl)thio]-N-(5-ethyl-1,3,4-thiadiazol-2-yl)acetamide; 2-({1,4-Dihydro-5,6-dimethyl-4-oxothieno[2,3-d]pyrimidin-2-yl}sulfanyl)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)acetamide; Acetamide, 2-[(5,6-dimethyl-1,4-dihydro-4-oxothieno[2,3-d]pyrimidin-2-yl)thio]-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-; Thieno[2,3-d]pyrimidine acetamide derivative; CAS 606108-38-7
EINECS	Contact for details

Quality Control

Our Acetamide, 2-[(1,4-Dihydro-5,6-Dimethyl-4-Oxothieno[2,3-D]Pyrimidin-2-Yl)Thio]-n-(5-Ethyl-1,3,4-Thiadiazol-2-Yl)- (9Ci) is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We support cGMP compliance for pharmaceutical applications, and specifications can be aligned with client-specific requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). The compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere if specified. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.